D4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs

Psychopharmacology

Volumn 120, Issue 3, 1995, Pages 365-368

  Roth, B L ^a   Tandra, S ^a   Burgess, L H ^b   Sibley, D R ^b   Meltzer, H Y ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Antipsychotic drugs; D4 dopamine receptor; Rat

Indexed keywords

CLOZAPINE; DOPAMINE RECEPTOR; NEUROLEPTIC AGENT; RISPERIDONE; SEROTONIN RECEPTOR; SPIPERONE; 2 CHLORO 11 (3 DIMETHYLAMINOPROPYLIDENE)MORPHANTHRIDINE; AMOXAPINE; CHLORPROMAZINE; DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR; FLUPERLAPINE; FLUPHENAZINE; HALOPERIDOL; LOXAPINE; MELPERONE; MESORIDAZINE; N CYCLOHEXYL 4 [4 (4 FLUOROPHENYL) 4 OXOBUTYL] 1 PIPERAZINECARBOXAMIDE; OLANZAPINE; PENFLURIDOL; PIMOZIDE; QUETIAPINE; SEROTONIN 2A RECEPTOR; TENILAPINE; THIORIDAZINE; TIOSPIRONE; TIOTIXENE; TRIFLUOPERAZINE; ZOTEPINE;

ANIMAL; ARTICLE; BINDING COMPETITION; CLASSIFICATION; DRUG EFFECT; GENETICS; RAT; RAT STRAIN; CONTROLLED STUDY; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY;

ANIMALS; ANTIPSYCHOTIC AGENTS; BINDING, COMPETITIVE; CLOZAPINE; RATS; RATS, INBRED STRAINS; RECEPTORS, DOPAMINE; RECEPTORS, SEROTONIN; RISPERIDONE; SPIPERONE;

EID: 0028990758     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/BF02311185     Document Type: Article

References (21)

1. Dopamine neurochemical profile of atypical antipsychotics resemble that of D-1 antagonists
2. Evidence for different affinity states of the dopamine D-1 receptor: clozapine and fluperlapine may preferentially label an adenylate cyclase-coupled state of the D-1 receptor
3. Dopamine D4 receptor repeat: analysis of distinct native and mutant forms of the human and rat genes
4. Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in chinese hamster ovary cells
5. Expression and characterization of rat D4-D2 chimeric dopamine receptors
6. In vivo potencies of antipsychotic drugs in blocking alphal noradrenergic and dopamine D-2 receptors: implications for drug mechanisms of action
7. Clozapine for the treatment-resistant schizophrenic
8. DopamineD4 versus D2 receptor selectivity of dopamine receptor antagonists: possible therapeutic implications
9. Effect of clozapine in severe tardive dyskinesia
10. Effect of clozapine on human serum prolactin levels
11. Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values
12. Anti-muscarinic properties of neuroleptics and drug-induced parkinsonism
13. LIGAND: a versatile, computerized approach for characterization of ligand-binding systems
14. Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity
15. Binding of typical and atypical antipsychotic agents with transiently expressed 5-HT1c receptors
16. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine6 (5-HT6) and 5-hydroxytryptamine (5-HT7) receptors
17. 5-HT2 receptor blockade by ICI 169,369 and other 5-HT2 antagonists modulates the effects of D-2 dopamine receptor blockade
18. Pharmacological and functional characterization of D2, D3 and D4 dopamine receptors in fibroblast and dopaminergic cell lines
19. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine
20. Clozapine is a potent and selective muscarinic M4 receptor agonist